Suggest an update

YC W22 · Active

Alixia

Targeting the Tumor Ecosystem to address cancer drug resistance.

Class
Winter 2022
Status
Active
Industry
Healthcare
Location
San Francisco, CA, USA
Team size
2

Website

http://www.alixia.com

About

Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.